Slc25a13-Knockout Mice Harbor Metabolic Deficits but Fail to Display Hallmarks of Adult-Onset Type II Citrullinemia

Molecular and Cellular Biology

Volumn 24, Issue 2, 2004, Pages 527-536

  Sinasac, David S ^a,b   Moriyama, Mitsuaki ^c   Jalil, M Abdul ^d   Begum, Laila ^d   Li, Meng Xian ^d   Iijima, Mikio ^d   Horiuchi, Masahisa ^d   Robinson, Brian H ^a   Kobayashi, Keiko ^d   Saheki, Takeyori ^d   Tsui, Lap Chee ^a,b,e  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Osaka Prefecture University   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMMONIA; ARGININOSUCCINATE SYNTHASE; ASPARTIC ACID; ERIODICTYOL 7 O GLUCOSIDE; GLUCOSE; GLUTAMIC ACID; LACTIC ACID; MALIC ACID; MESSENGER RNA; NITROGEN; PROTEIN; PYRUVIC ACID; UNCLASSIFIED DRUG;

AGE; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CITRULLINEMIA; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ETHNOLOGY; GENE; GENE MUTATION; GENETIC CODE; GLUCONEOGENESIS; GLUCOSE METABOLISM; HEREDITY; HYPERAMMONEMIA; KNOCKOUT MOUSE; LIVER CELL; LIVER MITOCHONDRION; LIVER PERFUSION; METABOLIC DISORDER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONSET AGE; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SLC25A13 GENE; SYMPTOM; UREA CYCLE;

AMINO ACIDS; AMMONIA; ANIMALS; ARGININOSUCCINATE SYNTHASE; ASPARTIC ACID; BASE SEQUENCE; CITRULLINEMIA; DISEASE MODELS, ANIMAL; DNA; FEMALE; GLUCONEOGENESIS; HUMANS; LIVER; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; MITOCHONDRIAL PROTEINS; MUTATION; NAD; PHENOTYPE; RNA, MESSENGER; UREA;

ANIMALIA; EQUUS ASINUS;

EID: 9144245537     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.2.527-536.2004     Document Type: Article

References (53)

1. Azzi, A., J. B. Chappell, and B. H. Robinson. 1967. Penetration of the mitochondrial membrane by glutamate and aspartate. Biochem. Biophys. Res. Commun 29:148-152.
2. Begum, L., M. A. Jalil, K. Kobayashi, M. lijima, M. X. Li, T. Yasuda, M. Horiuchi, A. del Arco, J. Satrústegui, and T. Saheki. 2002. Expression of three mitochondrial solute carriers, citrin, aralarl and ornithine transporter, in relation to urea cycle in mice. Biochim. Biophys. Acta 1574:283-292.
3. Ben-Shalom, E., K. Kobayashi, A. Shaag, T. Yasuda, H. Z. Gao, T. Saheki, C. Bachmann, and O. Elpeleg. 2002. Infantile citrullinemia caused by citrin deficiency with increased dibasic amino acids. Mol. Genet. Metab. 77:202-208.
4. Borst, P. 1963. Hydrogen transport and transport metabolites, p. 137-162., In P. Karson (ed.), Funktionelle und morphologische Organization der Zelle. Springer-Verlag KG, Heidelberg, Germany.
5. Burnett, W. V. 1997. Northern blotting of RNA denatured in glyoxal without buffer recirculation. BioTechniques 22: 668-671.
6. del Arco, A., M. Agudo, and J. Satrústegui. 2000. Characterization of a second member of the subfamily of calcium-binding mitochondrial carriers expressed in human non-excitable tissues. Biochem. J. 345:725-732.
7. del Arco, A., and J. Satrústegui. 1998. Molecular cloning of aralar, a new member of the mitochondrial carrier superfamily that binds calcium and is present in human muscle and brain. J. Biol. Chem. 273:23327-23334.
8. Gao, H. Z., K. Kobayashi, A. Tabata, H. Tsuge, M. Iijima, T. Yasuda, H. S. Kalkanoglu, A. Dursun, A. Tokatli, T. Coskun, F. K. Trefz, D. Skladal, H. Mandel, J. Seidel, S. Kodama, S. Shirane, T. Ichida, S. Makino, M. Yoshino, J. H. Kang, M. Mizuguchi, B. A. Barshop, S. Fuchinoue, S. Seneca, S. Zeesman, I. Knerr, M. Rodes, P. Wasant, I. Yoshida, L. De Meirleir, M. Abdul Jalil, L. Begum, M. Horiuchi, N. Katunuma, S. Nakagawa, and T. Saheki. 2003. Identification of 16 novel mutations in the argininosuccinate synthetase gene and genotype-phenotype-correlation in 38 classical citrullinemia patients. Hum. Mutat. 22:24-34.
9. Hogeboom, G. H. 1955. Fractionation of cell components of animal tissues. Methods Enzymol. 1:16-19.
10. Iijima, M., A. Jalil, L. Begum, T. Yasuda, N. Yamaguchi, M. Xian Li, N. Kawada, H. Endou, K. Kobayashi, and T. Saheki. 2001. Pathogenesis of adult-onset type II citrullinemia caused by deficiency of citrin, a mitochondrial solute carrier protein: tissue and subcellular localization of citrin. Adv. Enzyme Regul. 41:325-342.
11. Ikeda, S., M. Yazaki, Y. Takei, T. Ikegami, Y. Hashikura, S. Kawasaki, M. Iwai, K. Kobayashi, and T. Saheki. 2001. Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation. J. Neurol. Neurosurg. Psychiatry 71:663-670.
12. Imamura, Y., K. Kobayashi, T. Shibatou, S. Aburada, K. Tahara, O. Kubozono, and T. Saheki. 2003. Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol. Res. 26:68-72.
13. Kobayashi, K., M. Horiuchi, and T. Saheki. 1997. Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia. Hepatology 25:1160-1165.
14. Kobayashi, K., M. Ijima, T. Yasuda, D. S. Sinasac, N. Yamaguchi, L.-C. Tsui, S. W. Scherer, and T. Saheki. 2000. Type II citrullinemia (citrin deficiency): A mysterious disease caused by a defect of calcium-binding mitochondrial carrier protein, p. 565-587. In R. Pochet, R. Donato, J. Haiech, C. W. Heizmann, and V. Gerke (ed.), Calcium: the molecular basis of calcium action in biology and medicine. Kluwer Academic Publishers Dordrecht, The Netherlands.
15. Kobayashi, K., M. J. Jackson, D. B. Tick, W. E. O'Brien, and A. L. Beaudet. 1990. Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia. J. Biol. Chem. 265:11361-11367.
16. Kobayashi, K., M. Nakata, H. Terazono, T. Shinsato, and T. Saheki. 1995. Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult-onset type II citrullinemia. FEBS Lett. 372:69-73.
17. Kobayashi, K., T. Saheki, Y. Imamura, T. Noda, I. Inoue, S. Matuo, S. Hagihara, H. Nomiyama, Y. Jinno, and K. Shimada. 1986. Messenger RNA coding for argininosuccinate synthetase in citrullinemia. Am, J. Hum. Genet. 38:667-680.
18. Kobayashi, K., N. Shaheen, R. Kumashiro, K. Tanikawa, W. E. O'Brien, A. L. Beaudet, and T. Saheki. 1993. A search for the primary abnormality in adult-onset type II citrullinemia. Am. J. Hum. Genet. 53:1024-1030.
19. Kobayashi, K., D. S. Sinasac, M. Iijima, A. P. Boright, L. Begum, J. R. Lee, T. Yasuda, S. Ikeda, R. Hirano, H. Terazono, M. A. Crackower, I. Kondo, L. C. Tsui, S. W. Scherer, and T. Saheki. 1999. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat. Genet. 22:159-163.
20. Krebs, H. A., P. Lund, and M. Stubbs. 1976. Interrelations between gluconeogenesis and urea synthesis, p. 269-291. In R. W. Hanson, M. A. Mehlman, and H, A. Lardy (ed.), Gluconeogenesis, its regulation in mammalian species. Wiley, New York, N.Y.
21. LaNoue, K. F., and J. R. Williamson. 1971. Interrelationships between malate-aspartate shuttle and citric acid cycle in rat heart mitochondria. Metabolism 20:119-140.
22. Li, M. X., T. Nakajima, T. Fukushige, K. Kobayashi, N. Seiler, and T. Saheki. 1999. Aberrations of ammonia metabolism in ornithine carbamoyl-transferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator. Biochim. Biophys. Acta 1455:1-11.
23. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
24. McMurray, W. C., F. Mohyuddin, R. J. Rossiter, J. C. Rathburn, G. H. Valentine, S. J. Koegler, and D. E. Zarfas. 1962. Citrullinemia: a new aminoaciduria associated with mental retardation. Lancet 1:138
25. Meijer, A. J.,J. A. Gimpel, G. Deleeuw, M. E. Tischler, J. M. Tager, and J. R. Williamson. 1978. Interrelationships between gluconeogenesis and ureogenesis in isolated hepatocytes. J. Biol. Chem. 253:2308-2320.
26. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
27. Nagata, N., I. Matsuda, and K. Oyanagi. 1991. Estimated frequency of urea cycle enzymopathies in Japan. Am. J. Med. Genet. 39:228-229.
28. Nagy, A., J. Rossant, R. Nagy, W. Abramow-Newerly, and J. C. Roder. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90:8424-8428.
29. Naito, E., M. Ito, S. Matsuura, Yokota, T. Saijo, Y. Ogawa, S. Kitamura, K. Kobayashi, T. Saheki, Y. Nishimura, N. Sakura, and Y. Kuroda. 2002. Type II citrullinaemia (citrin deficiency) in a neonate with hypergalactosaemia detected by mass screening. J. Inherit. Metab. Dis. 25:71-76.
30. Nakajima, T., M. Horiuchi, H. Yamanaka, Z. Kizaki, F. Inoue, N. Kodo, A. Kinugasa, T. Saheki, and T. Sawada. 1997. The effect of camitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency. Pediatr. Res. 42:108-113.
31. Ohura, T., K. Kobayashi, Y. Tazawa, I. Nishi, D. Abukawa, O. Sakamoto, K. Iinuma, and T. Saheki. 2001. Neonatal presentation of adult-onset type II citrullinemia. Hum. Genet. 108:87-90.
32. 2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J. 20:5060-5069.
33. Sadava, D., M. Depper, M. Gilbert, B. Bernard, and E. R. McCabe. 1987. Development of enzymes of glycerol metabolism in human fetal liver. Biol. Neonate 52:26-32.
34. Saheki, T., and K. Kobayashi. 2002. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J. Hum. Genet. 47: 333-341.
35. Saheki, T., K. Kobayashi, and I. Inoue. 1987. Hereditary disorders of the urea cycle in man: biochemical and molecular approaches. Rev. Physiol. Biochem. Pharmacol. 108:21-68.
36. Saheki, T., K. Kobayashi, I. Inoue, S. Matuo, S. Hagihara, and T. Noda. 1987. Increased urinary excretion of argininosuccinate in type II citrullinemia. Clin. Chim. Acta 170:297-304.
37. Saheki, T., K. Kobayashi, T. Miura, S. Hashimoto, Y. Ueno, T. Yamasaki, H. Araki, H. Nara, Y. Shiozaki, Y. Sameshima, M. Suzuki, Y. Yamauchi, Y. Sakazume, K. Akiyama, and Y. Yamamura. 1986. Serum amino acid pattern of type II citrullinemic patients and effect of oral administration of citrulline. J. Clin. Biochem. Nutr. 1:129-142.
38. Saheki, T., M. Sase, K. Nakano, and Y. Yagi. 1985. Arginine metabolism in citrullinemic patients, p. 149-158. In A. Mori, B. D. Cohen, and A. Lowenthal (ed.), Guanidines, Plenum Press, New York, N.Y.
39. Saheki, T., A. Ueda, M. Hosoya, K. Kusumi, S. Takada, M. Tsuda, and T. Katsunuma. 1981. Qualitative and quantitative abnormalities of arginino-succinate synthetase in citrullinemia. Clin. Chim. Acta 109:325-335.
40. Saheki, T., A. Ueda, M. Hosoya, M. Sase, K. Nakano, and T. Katsunuma. 1983. Enzymatic analysis of citrullinemia (12 cases) in Japan. Adv. Exp. Med. Biol. 153:63-76.
41. Saheki, T., A. Ueda, K. Iizima, N. Yamada, K. Kobayashi, K. Takahashi, and T. Katsunuma. 1982. Argininosuccinate synthetase activity in cultured skin fibroblasts of citrullinemic patients. Clin. Chim. Acta 118:93-97.
42. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
43. Scholz, T. D., and S. L. Koppenhafer. 1995. Reducing equivalent shuttles in developing porcine myocardium: enhanced capacity in the newborn heart. Pediatr. Res. 38:221-227.
44. Shiota, M., M. Hiramatsu, Y. Fujimoto, M. Moriyama, K. Kimura, M. Ohta, and T. Sugano. 1994. The capacity of the malate-aspartate shuttle differs between periportal and perivenous hepatocytes from rats. Arch. Biochem. Biophys. 308:349-356.
45. Sinasac, D. S., M. A. Crackower, J. R. Lee, K. Kobayashi, T. Saheki, S. W. Scherer, and L. C. Tsui. 1999. Genomic structure of the adult-onset type II citrullinemia gene, SLC25A13, and cloning and expression of its mouse homologue. Genomics 62:289-292.
46. Svensson, G., and T. Anfalt. 1982. Rapid determination of ammonia in whole blood and plasma using flow injection analysis. Clin. Chim. Acta 119:7-14.
47. Tamamori, A., Y. Okano, H. Ozaki, A. Fujimoto, M. Kajiwara, K. Fukuda, K. Kobayashi, T. Saheki, Y. Tagami, and T. Yamano. 2002. Neonatal intrahepatic cholestasis caused by citrin deficiency: severe hepatic dysfunction in an infant requiring liver transplantation. Eur. J. Pediatr., 161:609-613.
48. Tazawa, Y., K. Kobayashi, T. Ohura, D. Abukawa, F. Nishinomiya, Y. Hosoda, M. Yamashita, I. Nagata, Y. Kono, T. Yasuda, N. Yamaguchi, and T. Saheki. 2001. Infantile cholestatic jaundice associated with adult-onset type II citrullinemia. J. Pediatr. 138:735-740.
49. Tomomasa, T., K. Kobayashi, H. Kaneko, H. Shimura, T. Fukusato, M. Tabata, Y. Inoue, S. Ohwada, M. Kasahara, Y. Morishita, M. Kimura, T. Saheki, and A. Morikawa. 2001. Possible clinical and histologic manifestations of adult-onset type II citrullinemia in early infancy. J. Pediatr. 138:741-743.
50. Williamson, J. R., and B. E. Corkey. 1969. Assays of intermediates of the citric acid cycle and related compounds by fluorometric enzyme methods, p. 434-509. In J. M. Lowenstein (ed.), Methods in enzymology: citric acid cycle. Academic Press, New York, N.Y.
51. Williamson, J. R., B. Safer, K. F. LaNoue, C. M. Smith, and E. Walajtys. 1973. Mitochondrial-cytosolic interactions in cardiac tissue: role of the malate-aspartate cycle in the removal of glycolytic NADH from the cytosol. Symp. Soc. Exp. Biol. 27:241-281.
52. Yamaguchi, N., K. Kobayashi, T. Yasuda, I. Nishi, M. Iijima, M. Nakagawa, M. Osame, I. Kondo, and T. Saheki. 2002. Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations. Hum. Mutat. 19:122-130.
53. Yasuda, T., N. Yamaguchi, K. Kobayashi, I. Nishi, H. Horinouchi, M. A. Jalil, M. X. Li, M. Ushikai, M. Iijima, I. Kondo, and T. Saheki. 2000., Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum. Genet. 107:537-545.